Research map: Rethinking glioma-associated senescence: Drivers of heterogeneity and therapeutic resistance

Back to the article

Papers in this map

  1. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma · Anoop P. Patel · 2014 · 5446 citations · Cited by this paper
  2. Understanding tumor heterogeneity: Implications for precision oncology and therapeutic strategies · 2026 · Related
  3. A proteomic atlas of senescence-associated secretomes for aging biomarker development · Nathan Basisty · 2020 · 1381 citations · Cited by this paper
  4. Mitochondria-mediated tumor drug resistance: From mechanism insights to therapeutic strategies · 2026 · Related
  5. Senolytic drugs: from discovery to translation · James L. Kirkland · 2020 · 1230 citations · Cited by this paper
  6. Temporal and spatial molecular heterogeneity of gastric cancer: Roles of post-translational modifications · 2026 · Related
  7. The senescence-associated secretory phenotype and its physiological and pathological implications · Boshi Wang · 2024 · 871 citations · Cited by this paper
  8. Nerve growth factor receptor (NGFR): A key player in glioblastoma progression · 2026 · Related
  9. Senescence and cancer — role and therapeutic opportunities · Clemens A. Schmitt · 2022 · 787 citations · Cited by this paper
  10. Post-translational modifications as hubs of amino acid metabolism in cancer: From oncogenic signaling to therapeutic targeting · 2026 · Related
  11. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy · Zizhao Mai · 2024 · 386 citations · Cited by this paper
  12. Neoantigen-driven personalized vaccines for breast cancer: Platforms, nano-delivery systems, and combination strategies · 2026 · Related
  13. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives · Hao Lin · 2024 · 378 citations · Cited by this paper
  14. Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements · 2024 · Related
  15. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion · Ester Gangoso · 2021 · 372 citations · Cited by this paper
  16. Emerging Advancements in Metabolic Properties of Macrophages within Disease Microenvironment for Immune Therapy · 2025 · Related
  17. Single-cell proteomics enabled by next-generation sequencing or mass spectrometry · Hayley M. Bennett · 2023 · 356 citations · Cited by this paper
  18. Immunosenescence and cancer: molecular hallmarks, tumor microenvironment remodeling, and age-specific immunotherapy challenges · 2025 · Related
  19. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis? · Naoko Ohtani · 2022 · 286 citations · Cited by this paper
  20. Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy · 2025 · Related
  21. Glioblastoma at the crossroads: current understanding and future therapeutic horizons · Shilpi Singh · 2025 · 272 citations · Cited by this paper
  22. Cellular senescence and SASP in tumor progression and therapeutic opportunities · Zening Dong · 2024 · 250 citations · Cited by this paper
  23. Senolytics and senostatics as adjuvant tumour therapy · Susan C Short · 2019 · 219 citations · Cited by this paper
  24. CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy · Michael C. Burger · 2019 · 213 citations · Cited by this paper
  25. Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence · Eliot Fletcher-Sananikone · 2021 · 212 citations · Cited by this paper
  26. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR–CHK1, p21, and NF-κB · Dorthe Aasland · 2018 · 205 citations · Cited by this paper
  27. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment · Yan Zou · 2023 · 181 citations · Cited by this paper
  28. Senescence-Associated β-Galactosidase Detection in Pathology · Yana Valieva · 2022 · 178 citations · Cited by this paper
  29. Cellular senescence and the tumour microenvironment · Masaki Takasugi · 2022 · 177 citations · Cited by this paper
  30. Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs · Natálie Kudlová · 2022 · 173 citations · Cited by this paper
  31. Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer · Cecilia R. Chambers · 2021 · 172 citations · Cited by this paper
  32. Senescence as a therapeutic target in cancer and age-related diseases · Domhnall McHugh · 2024 · 168 citations · Cited by this paper
  33. The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1 · Boyi Zhang · 2018 · 163 citations · Cited by this paper
  34. Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies · Vasco Lucas · 2023 · 156 citations · Cited by this paper
  35. The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature · Victor M. Lu · 2020 · 152 citations · Cited by this paper
  36. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy · Loretah Chibaya · 2022 · 141 citations · Cited by this paper
  37. The role of cellular senescence in skin aging and age-related skin pathologies · Toby Chin · 2023 · 135 citations · Cited by this paper
  38. Induction of senescence in human malignant glioma cells by p16INK4A · Lene Uhrbom · 1997 · 133 citations · Cited by this paper
  39. Berberine Induces Senescence of Human Glioblastoma Cells by Downregulating the EGFR–MEK–ERK Signaling Pathway · Qiao Liu · 2014 · 133 citations · Cited by this paper

Source: OpenAlex (CC0)